Loading...
XNAS
BIOX
Market cap235mUSD
Jul 25, Last price  
3.75USD
1D
1.35%
1Q
-12.79%
IPO
-61.10%
Name

Bioceres Crop Solutions Corp

Chart & Performance

D1W1MN
P/E
72.51
P/S
0.51
EPS
0.05
Div Yield, %
—
Shrs. gr., 5y
15.81%
Rev. gr., 5y
23.73%
Revenues
465m
+10.82%
5,100,39593,706,738133,491,118160,308,979172,350,699206,697,620328,455,588419,446,439464,828,548
Net income
3m
-82.73%
-1,194,011-11,817,854-11,039,533-18,369,0453,359,175-6,870,163-7,199,61818,779,8763,243,361
CFO
42m
+1,511.43%
-1,118,52419,101,25418,386,86829,694,8139,318,479-6,205,943-17,515,3742,588,79241,716,586

Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
URL
https://biocerescrops.com/
IPO date
Mar 22, 2018
Employees
400
Domiciled in
KY
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062015‑12
Income
Revenues
464,829
10.82%
419,446
27.70%
Cost of revenue
394,689
341,481
Unusual Expense (Income)
NOPBT
70,139
77,966
NOPBT Margin
15.09%
18.59%
Operating Taxes
3,779
(1,069)
Tax Rate
5.39%
NOPAT
66,361
79,034
Net income
3,243
-82.73%
18,780
-360.85%
Dividends
Dividend yield
Proceeds from repurchase of equity
(734)
(2,997)
BB yield
0.10%
0.36%
Debt
Debt current
139,870
111,498
Long-term debt
142,360
159,804
Deferred revenue
1,925
2,058
Other long-term liabilities
4,057
5,093
Net debt
185,640
171,509
Cash flow
Cash from operating activities
41,717
2,589
CAPEX
(9,790)
(22,563)
Cash from investing activities
(28,728)
(25,726)
Cash from financing activities
(10,056)
32,954
FCF
42,559
14,520
Balance
Cash
56,169
60,052
Long term investments
40,421
39,742
Excess cash
73,348
78,821
Stockholders' equity
54,517
18,871
Invested Capital
571,975
576,188
ROIC
11.56%
17.43%
ROCE
10.61%
12.36%
EV
Common stock shares outstanding
63,485
63,186
Price
11.21
-16.09%
13.36
-2.55%
Market cap
711,672
-15.69%
844,158
45.55%
EV
933,392
1,047,313
EBITDA
91,435
97,356
EV/EBITDA
10.21
10.76
Interest
26,872
21,230
Interest/NOPBT
38.31%
27.23%